Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced that its wholly owned subsidiary, MindWave Innovations Inc. USA, has entered into three separate agreements to build and operate dedicated blockchain networks on its MindChain infrastructure. The agreements, signed between Sept. 24 and Oct. 4, 2026, span three distinct industries: climate finance, sports media, and insurance. The clients include Singapore-based AQUAE Holdings for its AQUAEChain environmental credit platform, New York-based Flash Sports & Media Holdings for its FlashChain digital ticketing and media authentication network, and Delaware-based BlockAssure for its AssureChain insurance and reinsurance network. Under the terms, MindWave will receive contracted fees or equity, along with allocations equal to 20% of the applicable credits or tokens, providing opportunities for recurring revenue as the networks become operational. This diversification into multiple sectors demonstrates the versatility of MindChain and could position MindWave as a key player in the blockchain infrastructure space.
However, the announcement was accompanied by a sobering disclosure: Apimeds reiterated that its audited consolidated financial statements for 2025 included an explanatory paragraph from its independent auditor expressing substantial doubt about its ability to continue as a going concern. The disclosure was made pursuant to NYSE American requirements and does not amend the company’s previous filings. This raises questions about the company's financial health and its ability to execute on these new agreements. Investors can view the full press release at https://ibn.fm/UPsNX and stay updated on APUS news at https://ibn.fm/APUS.
The three agreements highlight MindWave's strategy to expand its blockchain solutions into emerging commercial ecosystems. AQUAEChain aims to support environmental credit trading, FlashChain focuses on digital ticketing and media authentication, and AssureChain targets insurance and reinsurance processes. Each network will leverage MindChain's transparent, traceable, and verifiable ledger capabilities. By securing these deals, MindWave not only gains immediate fees or equity but also positions itself to earn a significant share of the digital assets generated by these platforms. This could lead to substantial recurring revenue streams if the networks gain traction.
Yet the going concern warning casts a shadow over these developments. A going concern qualification indicates that there is substantial doubt about the company's ability to meet its financial obligations over the next year. For Apimeds, this may signal potential liquidity issues or operational challenges that could hinder its ability to support MindWave's projects. Investors will need to weigh the promising revenue potential against the risk that the company may not have the resources to fully capitalize on these opportunities. The disclosure, while required by NYSE American, serves as a reminder of the volatility and risk inherent in early-stage blockchain ventures.
MissionIR, a communications platform that assists IR firms with syndicated content, distributed the announcement. MissionIR is part of the Dynamic Brand Portfolio at IBN, which offers wire solutions through InvestorWire, editorial syndication to 5,000+ outlets, press release enhancement, social media distribution, and corporate communications solutions. For more information, visit MissionIR. The full terms of use and disclaimers are available at https://www.MissionIR.com/Disclaimer.
